Medtech CEO rails against DOJ at industry conference
Howard Root, CEO of Vascular Solutions, was declared not guilty of illegally promoting a medical device after a Department of Justice investigation that spanned several years.
Vein access company signs agreement with imaging firm to help clinicians see veins more clearly
A Minneapolis company has inked a marketing and distribution agreement with a vascular imaging company that aims to help clinicians see veins much more clearly. Publicly held Vascular Solutions (NASDAQ:VASC) said that the three-year marketing agreement with VueTek Scientific LLC that runs through Dec. 31, 2015 will put its Veinsite vascular imaging system in the […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Vascular Solutions reports seventh year of double-digit revenue growth
Vascular Solutions makes new innovative medical devices for peripheral and coronary arteries. Net revenue for the fourth quarter ending Dec. 31 increased 15 percent compared to last year's fourth quarter. Net revenue for the year was also up 15 percent to a record-setting $78.4 million.
Vascular Solutions establishes a firm Root in local medical device industry
Howard Root wants you to know that he’s not an angry man. Really. Yes, the CEO of Vascular Solutions Inc. (NASDAQ: VASC) sued another company for product defamation (Vascular won $3.5 million), tangled with local reporters (not me, at least not yet), and threatened not to develop any new products with Minnesota doctors if the […]
Minnesota’s public medical companies not named Medtronic are shrinking
Ernie Andberg has a little more free time on his hands these days. The long-time “emerging medical device companies” equity analyst for Feltl & Co. in Minneapolis has not seen a lot of companies emerging lately. In fact, they’ve been disappearing all together. Case in point: Medtronic Inc.’s (NYSE: MDT) deal last week to acquire […]
Vascular Solutions buys vein-access technologies for $5.75M
Vascular Solutions Inc. (Nasdaq: VASC) has acquired for $5.75 million two vein-access technologies that are used in ultrasound procedures. The company expects the new products to begin paying immediate dividends and upped its full-year guidance by $2 million. The two products — Smartneedle and PDaccess — come from Wayne, Penn.-based Escalon Medical Corporation (Nasdaq: ESMC), […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
BIO 2010: Minnesota faces crossroads in its high-tech future
To BIO or not to BIO? That’s the question confronting Minnesota as it ponders its economic future. In some ways, the answer is obvious. The state boasts a lot of expertise and money in medical technology. Lawmakers have already earmarked millions of dollars to build a “Biomedical Discovery District” in Minneapolis and an “Elk Run […]
St. Cloud State adds master’s degree program for medical device trials
One big gripe about Minnesota’s medical device community is the lack of college graduates ready to hit the ground running. Speaking at a governor candidates forum last week, Vascular Solutions CEO Howard Root said finding enough workers, including quality engineers and regulatory specialists, is the “number one obstacle” facing his company. He took direct aim […]
Minnesota guv candidates try to woo biotech crowd (with, um, mixed results)
It’s always a tough act to follow Howard Root, the sometimes volatile, always interesting CEO of Vascular Solutions Inc. But when you’re one of a gazillion candidates running for the governor of Minnesota, the challenge becomes even more daunting. Which makes me wonder why organizers of the first annual Minnesota BIO forum, including LifeScience Alley, […]
Minnesota’s Vascular Solutions gets FDA clearance for catheter
This is one of four devices Vascular Solutions expects to launch in the final months of 2009. It recently compared the revenue potential of the GuideLiner with that of the ProntoV3, one of the company's "extraction" catheters that has accounted for roughly three-quarters of its $12.3 million in sales from that category so far this year.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.